285 related articles for article (PubMed ID: 28664446)
1. Postnatal Outcomes of Fetal Supraventricular Tachycardia: a Multicenter Study.
Hinkle KA; Peyvandi S; Stiver C; Killen SAS; Weng HY; Etheridge SP; Puchalski MD
Pediatr Cardiol; 2017 Oct; 38(7):1317-1323. PubMed ID: 28664446
[TBL] [Abstract][Full Text] [Related]
2. Low mortality in fetal supraventricular tachycardia: Outcomes in a 30-year single-institution experience.
O'Leary ET; Alexander ME; Bezzerides VJ; Drogosz M; Economy KE; Friedman KG; Pickard SS; Tworetzky W; Mah DY
J Cardiovasc Electrophysiol; 2020 May; 31(5):1105-1113. PubMed ID: 32100356
[TBL] [Abstract][Full Text] [Related]
3. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
van der Heijden LB; Oudijk MA; Manten GT; ter Heide H; Pistorius L; Freund MW
Ultrasound Obstet Gynecol; 2013 Sep; 42(3):285-93. PubMed ID: 23303470
[TBL] [Abstract][Full Text] [Related]
4. Postnatal Outcomes in Infants With a History of Fetal Supraventricular Tachycardia.
Carberry T; Arzu J; Coons D; Husain N; Gotteiner N; Webster G
JACC Clin Electrophysiol; 2022 Sep; 8(9):1145-1151. PubMed ID: 36137720
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of sotalol as first-line therapy for fetal supraventricular tachyarrhythmias.
Shah A; Moon-Grady A; Bhogal N; Collins KK; Tacy T; Brook M; Hornberger LK
Am J Cardiol; 2012 Jun; 109(11):1614-8. PubMed ID: 22444730
[TBL] [Abstract][Full Text] [Related]
6. Flecainide as first-line treatment for fetal supraventricular tachycardia.
Ekiz A; Kaya B; Bornaun H; Acar DK; Avci ME; Bestel A; Yildirim G
J Matern Fetal Neonatal Med; 2018 Feb; 31(4):407-412. PubMed ID: 28114840
[TBL] [Abstract][Full Text] [Related]
7. Fetal supraventricular tachycardia complicated by hydrops fetalis: a role for direct fetal intramuscular therapy.
Parilla BV; Strasburger JF; Socol ML
Am J Perinatol; 1996 Nov; 13(8):483-6. PubMed ID: 8989479
[TBL] [Abstract][Full Text] [Related]
8. [Results of prenatal management of fetuses with supraventricular tachycardia. A series of 66 cases].
Jouannic JM; Delahaye S; Le Bidois J; Fermont L; Villain E; Dommergues M; Dumez Y
J Gynecol Obstet Biol Reprod (Paris); 2003 Jun; 32(4):338-44. PubMed ID: 12843882
[TBL] [Abstract][Full Text] [Related]
9. Prenatal diagnosis and management of fetal supraventricular tachyarrhythmia and postnatal outcomes.
Demirci O; Tosun Ö; Bolat G
J Gynecol Obstet Hum Reprod; 2022 Mar; 51(3):102323. PubMed ID: 35063720
[TBL] [Abstract][Full Text] [Related]
10. Treatment, not delivery, of the late preterm and term fetus with supraventricular arrhythmia.
Holmes S; Hornberger LK; Jaeggi E; Howley L; Moon-Grady AJ; Uzun O; Kaizer A; Gilicze O; Cuneo BF
Ultrasound Obstet Gynecol; 2023 Oct; 62(4):552-557. PubMed ID: 37128167
[TBL] [Abstract][Full Text] [Related]
11. Antenatal Therapy for Fetal Supraventricular Tachyarrhythmias: Multicenter Trial.
Miyoshi T; Maeno Y; Hamasaki T; Inamura N; Yasukochi S; Kawataki M; Horigome H; Yoda H; Taketazu M; Nii M; Hagiwara A; Kato H; Shimizu W; Shiraishi I; Sakaguchi H; Ueda K; Katsuragi S; Yamamoto H; Sago H; Ikeda T;
J Am Coll Cardiol; 2019 Aug; 74(7):874-885. PubMed ID: 31416531
[TBL] [Abstract][Full Text] [Related]
12. Favourable outcome for hydrops or cardiac failure associated with fetal tachyarrhythmia: a 20-year review.
Tunca Sahin G; Beattie RB; Uzun O
Cardiol Young; 2022 Jul; 32(7):1077-1084. PubMed ID: 34551832
[TBL] [Abstract][Full Text] [Related]
13. Favorable neurodevelopmental outcome in a hypothyroid neonate following intracordal amiodarone for cardioversion of refractory supraventricular tachycardia in a fetus.
Capone CA; Gebb J; Dar P; Shenoy RU
J Neonatal Perinatal Med; 2014; 7(4):305-9. PubMed ID: 25468615
[TBL] [Abstract][Full Text] [Related]
14. Sotalol as an effective adjunct therapy in the management of supraventricular tachycardia induced fetal hydrops fetalis.
Refaat M; El Dick J; Sabra M; Bitar F; Tayeh C; Abutaqa M; Arabi M
J Neonatal Perinatal Med; 2020; 13(2):267-273. PubMed ID: 31707376
[TBL] [Abstract][Full Text] [Related]
15. Correlation of maternal flecainide concentrations and therapeutic effect in fetal supraventricular tachycardia.
Vigneswaran TV; Callaghan N; Andrews RE; Miller O; Rosenthal E; Sharland GK; Simpson JM
Heart Rhythm; 2014 Nov; 11(11):2047-53. PubMed ID: 25068572
[TBL] [Abstract][Full Text] [Related]
16. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
Jaeggi ET; Carvalho JS; De Groot E; Api O; Clur SA; Rammeloo L; McCrindle BW; Ryan G; Manlhiot C; Blom NA
Circulation; 2011 Oct; 124(16):1747-54. PubMed ID: 21931080
[TBL] [Abstract][Full Text] [Related]
17. Refractory supraventricular fetal tachycardia as a cause of non-immune hydrops: management conundrum.
Agarwal A; Saha SC; Kaur A; Naganur S
BMJ Case Rep; 2023 Dec; 16(12):. PubMed ID: 38154874
[TBL] [Abstract][Full Text] [Related]
18. Management of fetal tachyarrhythmia based on superior vena cava/aorta Doppler flow recordings.
Fouron JC; Fournier A; Proulx F; Lamarche J; Bigras JL; Boutin C; Brassard M; Gamache S
Heart; 2003 Oct; 89(10):1211-6. PubMed ID: 12975422
[TBL] [Abstract][Full Text] [Related]
19. The efficacy of flecainide versus digoxin in the management of fetal supraventricular tachycardia.
Frohn-Mulder IM; Stewart PA; Witsenburg M; Den Hollander NS; Wladimiroff JW; Hess J
Prenat Diagn; 1995 Dec; 15(13):1297-302. PubMed ID: 8710768
[TBL] [Abstract][Full Text] [Related]
20. Foetal supraventricular tachycardia with hydrops fetalis: a role for direct intraperitoneal amiodarone.
Kang SL; Howe D; Coleman M; Roman K; Gnanapragasam J
Cardiol Young; 2015 Mar; 25(3):447-53. PubMed ID: 24811422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
